201 related articles for article (PubMed ID: 15370819)
1. Methodology for applied 4 MHz RF hyperthermia concomitant with 31P NMR spectroscopic monitoring of murine tumours.
Bezabeh T; Evelhoch JL; Sloop DJ; Ackerman JJ
Int J Hyperthermia; 2004 Sep; 20(6):637-45. PubMed ID: 15370819
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy as predicted by quantitative assessment of murine RIF-1 tumour pH and phosphorous metabolite response during hyperthermia: an in vivo 31P NMR study.
Bezabeh T; Evelhoch JL; Thompson P; Sloop DJ; Ackerman JJ
Int J Hyperthermia; 2004 Jun; 20(4):335-57. PubMed ID: 15204517
[TBL] [Abstract][Full Text] [Related]
3. Loss of high-energy phosphate following hyperthermia demonstrated by in vivo 31P-nuclear magnetic resonance spectroscopy.
Lilly MB; Ng TC; Evanochko WT; Katholi CR; Kumar NG; Elgavish GA; Durant JR; Hiramoto R; Ghanta V; Glickson JD
Cancer Res; 1984 Feb; 44(2):633-8. PubMed ID: 6581861
[TBL] [Abstract][Full Text] [Related]
4. Antitumour effectiveness of hyperthermia is potentiated by local application of electric pulses to LPB tumours in mice.
Karner KB; Lesnicar H; Cemazar M; Sersa G
Anticancer Res; 2004; 24(4):2343-8. PubMed ID: 15330182
[TBL] [Abstract][Full Text] [Related]
5. Defining the pHi-hyperthermia sensitivity relationship for the RIF-1 tumor in vivo: a 31P MR spectroscopy study.
Spees WM; Evelhoch JL; Thompson PA; Sloop DJ; Ackerman JJ
Radiat Res; 2005 Jul; 164(1):86-99. PubMed ID: 15966768
[TBL] [Abstract][Full Text] [Related]
6. Controlled radio-frequency hyperthermia using an MR scanner and simultaneous monitoring of temperature and therapy response by (1)H, (23)Na and (31)P magnetic resonance spectroscopy in subcutaneously implanted 9L-gliosarcoma.
James JR; Gao Y; Soon VC; Topper SM; Babsky A; Bansal N
Int J Hyperthermia; 2010 Feb; 26(1):79-90. PubMed ID: 20100055
[TBL] [Abstract][Full Text] [Related]
7. Field-focusing hyperthermia and magnetic resonance imaging (MRI) with a grounded probe and a commercial MRI scanner.
Yamanashi WS; Fesen MR; Anderson DW; SY AM; Lester PD
Med Instrum; 1985; 19(5):217-23. PubMed ID: 4058345
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
[TBL] [Abstract][Full Text] [Related]
9. In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia.
Vaupel P; Okunieff P; Neuringer LJ
Int J Hyperthermia; 1990; 6(1):15-31. PubMed ID: 2299228
[TBL] [Abstract][Full Text] [Related]
10. Experience with a small animal hyperthermia ultrasound system (SAHUS): report on 83 tumours.
Novák P; Moros EG; Parry JJ; Rogers BE; Myerson RJ; Zeug A; Locke JE; Rossin R; Straube WL; Singh AK
Phys Med Biol; 2005 Nov; 50(21):5127-39. PubMed ID: 16237245
[TBL] [Abstract][Full Text] [Related]
11. Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy.
Chelvi TP; Ralhan R
Int J Hyperthermia; 1995; 11(5):685-95. PubMed ID: 7594819
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous evaluation of the effects of RF hyperthermia on the intra- and extracellular tumor pH.
Jayasundar R; Honess D; Hall LD; Bleehen NM
Magn Reson Med; 2000 Jan; 43(1):1-8. PubMed ID: 10642725
[TBL] [Abstract][Full Text] [Related]
13. [An interstitial miniature antenna for localized in vivo P-31 MR spectroscopy].
Hentschel M; Wust P; Fähling H; Richter R; Vogl T; Semmler W; Wolf KJ; Felix R
Strahlenther Onkol; 1996 Nov; 172(11):610-8. PubMed ID: 8975392
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models.
Kraybill WG; Olenki T; Evans SS; Ostberg JR; O'Leary KA; Gibbs JF; Repasky EA
Int J Hyperthermia; 2002; 18(3):253-66. PubMed ID: 12028640
[TBL] [Abstract][Full Text] [Related]
15. Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation.
Diederich CJ
Int J Hyperthermia; 2005 Dec; 21(8):745-53. PubMed ID: 16338857
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
17. Correlations between 31P NMR spectroscopy and 15O perfusion measurements in the RIF-1 murine tumor in vivo.
Evelhoch JL; Sapareto SA; Nussbaum GH; Ackerman JJ
Radiat Res; 1986 Apr; 106(1):122-31. PubMed ID: 3961103
[TBL] [Abstract][Full Text] [Related]
18. Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed.
Fatehi D; van der Zee J; van der Wal E; Van Wieringen WN; Van Rhoon GC
Int J Hyperthermia; 2006 Jun; 22(4):353-63. PubMed ID: 16754355
[TBL] [Abstract][Full Text] [Related]
19. 13.56 MHz hyperthermia temperature distribution in phantoms, and clinical results of therapy.
Herbst M
Radiat Med; 1985; 3(2):99-106. PubMed ID: 4081111
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of magnetic nanoparticles for hyperthermia.
Thiesen B; Jordan A
Int J Hyperthermia; 2008 Sep; 24(6):467-74. PubMed ID: 18608593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
